Smart device could revolutionize constipation treatment

NCT ID NCT05807321

Recruiting now Knowledge-focused Sponsor: The California Medical Innovations Institute, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new device called Fecobionics that measures how the rectum and anus work during bowel movements. Researchers want to see if it can predict which patients with a type of constipation called dyssynergia will benefit from biofeedback therapy. About 24 adults will be enrolled to test the device's accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fecobionics device
What this could lead to: If successful, this could lead to better prediction of which patients will benefit from biofeedback therapy, improving treatment for constipation.
What could go wrong: This is a small, early-stage study with only 24 participants, so results may not apply to everyone. The device is new and its effectiveness is unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anismus Ataxia constipation disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONSTIPATION DYSSYNERGIA

Contacts and locations

Locations

California Medical Innovations Institute
RECRUITING

San Diego, California, 92121, United States
Digestive Health Center- Augusta University
RECRUITING

Augusta, Georgia, 30912, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.